Skip to content

Clinical trials

Observational Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Phase: Observational Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20093
20113
20131
20143
20153
20164
20171
20183
20197
20208
20219
20226
20237
20246
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting26
Unknown status13
Withdrawn4
Not yet recruiting3
Active, not recruiting3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals5
The Cleveland Clinic4
Fondazione IRCCS Policlinico San Matteo di Pavia3
Mayo Clinic3
University of Texas Southwestern Medical Center3
AstraZeneca2
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla2
Hospital Italiano de Buenos Aires2
Ionis Pharmaceuticals, Inc.2
Oregon Health and Science University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis81
Amyloid Neuropathies, Familial19
Cardiomyopathies14
Immunoglobulin Light-chain Amyloidosis12
Alzheimer Disease7
Multiple Myeloma7
Amyloidosis, Familial6
Polyneuropathies6
Heart Failure5
Aortic Valve Stenosis4

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.